Martha Alicia Ornelas

Person

  • San Diego, CA, US

Patents Grantslast 30 patents

  • Information Patent Grant

    CDK2/4/6 inhibitors

    • Patent number 11,396,512
    • Issue date Jul 26, 2022
    • Pfizer Inc.
    • Douglas Carl Behenna
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    CDK2/4/6 inhibitors

    • Patent number 10,800,783
    • Issue date Oct 13, 2020
    • Pfizer Inc.
    • Douglas Carl Behenna
    • C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

  • Information Patent Application

    CDK2/4/6 Inhibitors

    • Publication number 20220324872
    • Publication date Oct 13, 2022
    • Pfizer Inc.
    • Douglas Carl Behenna
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CRYSTALLINE FORM OF A CDK INHIBITOR

    • Publication number 20220127262
    • Publication date Apr 28, 2022
    • Pfizer Inc.
    • Douglas Carl Behenna
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    CDK2/4/6 Inhibitors

    • Publication number 20200392142
    • Publication date Dec 17, 2020
    • Pfizer Inc.
    • Douglas Carl Behenna
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CDK2/4/6 Inhibitors

    • Publication number 20190135817
    • Publication date May 9, 2019
    • Pfizer Inc.
    • Douglas Carl Behenna
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    CDK2/4/6 Inhibitors

    • Publication number 20180044344
    • Publication date Feb 15, 2018
    • Pfizer Inc.
    • Douglas Carl Behenna
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    HETEROCYCLES USEFUL AS INHIBITORS OF CARBONIC ANHYDRASE

    • Publication number 20100256357
    • Publication date Oct 7, 2010
    • Agouron Pharmaceuticals, Inc.
    • Wesley Kwan Mung Chong
    • C07 - ORGANIC CHEMISTRY